2026.08.25
Chemical and Structural Engineering of Guide RNAs for Precision Genome Editing: From Design Principles to Clinical Applications
An article on the research findings of Dr. Masaki Kawamata (Genome Regulation Medicine Lab) from the Convergence Research Promotion Office, the Research Institute for Cell Design Medical Science has been published in the “Chemical Biology & Drug Design.”
Overview
This paper focuses on guide RNA (gRNA)—a key component of CRISPR genome editing—and provides a comprehensive overview of the latest gRNA engineering technologies, including chemical modifications, structural alterations, and design using AI and machine learning.
The paper organizes the mechanisms by which these approaches enhance the efficiency, specificity, stability, and safety of genome editing, and highlights application examples in genome editing therapies and CRISPR diagnostics, where practical implementation and clinical development are already underway.
Furthermore, from the perspective of “How should gRNA be designed to deliver safer and more precise genome editing to clinical practice?”, the paper outlines future directions for gRNA development and prospects for clinical application.
Please click the following link for details.
https://onlinelibrary.wiley.com/doi/10.1111/cbdd.70377